Stockreport

Celldex prices $300M stock at $29 per share to fuel Barzolvolimab launch [Seeking Alpha]

Celldex Therapeutics, Inc.  (CLDX) 
Last celldex therapeutics, inc. earnings: 11/12 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com
PDF Subscribe to Newsletters Sign Up Celldex Therapeutics ( CLDX priced an underwritten public offering of ~10.3M shares at a public offering price of $29.00 per shar [Read more]